The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily ...

Pfizer’s stock has underperformed lately, falling 4.6% while still doing marginally better than its peers. Analysts have made ...

Pfizer's revenue has stabilized, and operational efficiency is improving, supporting a "Strong buy" rating with a 6.5% forward dividend yield. The market sentiment in the next few months is likely ...

Investing.com - U.S. stocks finished Friday mixed to higher, driven by an investor appetite for risk stemming from better than... Investing.com - U.S. stocks finished Friday mixed to higher ...

On an intraday basis between Feb. 18 and March 4, the innovation-driven Nasdaq Composite lost close to 11% of its value. Uncertainty tied to President Donald Trump's tariffs is the primarily ...

For the better part of the last 2.5 years, the bulls have been calling the shots on Wall Street. The ageless Dow Jones Industrial Average, benchmark S&P 500, and growth-dominated Nasdaq Composite ...

Asian shares were mostly lower on Monday after gains in technology stocks snapped Wall Street’s four-week losing streak. U.S.

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...